Clemson tight end Braden Galloway and offensive lineman Zach Giella have been ruled ineligible for the 2019 season after being denied a drug test appeal, the players's representative announced on Friday.
Galloway and Giella, along with defensive lineman Dexter Lawrence, tested positive for trace amounts of Ostarine in December, which caused them to miss Clemson’s College Football Playoff games against Notre Dame and Alabama.
According to the U.S. Anit-Doping Agency, Ostarine is defined as a Selective Androgen Receptor Modulator (SARM) that is not approved for human use or consumption in the United States or any other countries.